Meckel’s diverticulum is a rare congenital abnormality of the small intestine. It is believed to be caused by an incomplete closure of the vitelline duct, which is the embryonic precursor of the small intestine. The condition is often seen in infants and children, although it can be present in adults as well. Meckel’s diverticulum can be difficult to diagnose, as the symptoms can be similar to other gastrointestinal disorders. In this article, we will explore the history of Meckel’s diverticulum, its symptoms, diagnosis, and treatment.
Meckel’s diverticulum was first described by German physician Johann Friedrich Meckel in 1809. He noticed a small out-pouching of the small intestine in a cadaver and postulated that it was due to an incomplete closure of the vitelline duct. Since then, the condition has been named after him. Meckel’s diverticulum is the most common congenital abnormality of the small intestine. It is estimated to occur in 2-4% of the population, with a higher incidence in males. The condition is most commonly seen in infants and children, but can be present in adults as well.
Meckel’s diverticulum is often asymptomatic, meaning that it does not cause any symptoms. However, when symptoms do occur, they can range from mild to severe. The most common symptoms are abdominal pain, nausea, vomiting, and diarrhea. Other symptoms can include rectal bleeding, weight loss, and fever.
Meckel’s diverticulum can be difficult to diagnose, as the symptoms can be similar to other gastrointestinal disorders. The most common diagnostic test used to diagnose Meckel’s diverticulum is an abdominal ultrasound. This test can be used to detect the presence of a diverticulum in the small intestine. Other tests that may be used to diagnose Meckel’s diverticulum include a barium enema, a computed tomography (CT) scan, and an upper gastrointestinal (GI) series.
The treatment of Meckel’s diverticulum depends on the severity of the condition. In cases where the diverticulum is asymptomatic, no treatment may be necessary. However, if the diverticulum is causing symptoms, it may need to be surgically removed. This is known as a laparoscopic diverticulectomy.
Meckel’s diverticulum is a rare congenital abnormality of the small intestine. It is often asymptomatic, but can cause abdominal pain, nausea, vomiting, and diarrhea when symptoms do occur. Diagnosis is often done using an abdominal ultrasound, although other tests may be used as well. Treatment of Meckel’s diverticulum depends on the severity of the condition, but may involve surgical removal of the diverticulum. Despite its rarity, Meckel’s diverticulum is an important condition to be aware of. With early diagnosis and proper treatment, it can be managed effectively.
1.
Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth
2.
Detecting pancreatic cancer through changes in body composition and metabolism
3.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
4.
The pandemic had little impact on mental health symptoms.
5.
Men over 75 years old may be significantly more likely to commit suicide if they have cancer.
1.
From Muscle Soreness to Improved Endurance: The Benefits of Monitoring Lactic Acid Levels
2.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
3.
Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts
4.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
5.
Exploring the Unknown: Unveiling the Mysteries of GIST Tumors
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation